CA2384104A1 - Use of semaphorin for modulation of cellular efflux - Google Patents

Use of semaphorin for modulation of cellular efflux Download PDF

Info

Publication number
CA2384104A1
CA2384104A1 CA002384104A CA2384104A CA2384104A1 CA 2384104 A1 CA2384104 A1 CA 2384104A1 CA 002384104 A CA002384104 A CA 002384104A CA 2384104 A CA2384104 A CA 2384104A CA 2384104 A1 CA2384104 A1 CA 2384104A1
Authority
CA
Canada
Prior art keywords
semaphorin
leu
cell
polypeptide
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002384104A
Other languages
English (en)
French (fr)
Inventor
Melanie K. Spriggs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2384104A1 publication Critical patent/CA2384104A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4703Inhibitors; Suppressors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002384104A 1999-09-08 2000-09-07 Use of semaphorin for modulation of cellular efflux Abandoned CA2384104A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15291499P 1999-09-08 1999-09-08
US60/152,914 1999-09-08
US15625799P 1999-09-27 1999-09-27
US60/156,257 1999-09-27
US17390699P 1999-12-29 1999-12-29
US60/173,906 1999-12-29
PCT/US2000/024560 WO2001018044A2 (en) 1999-09-08 2000-09-07 Use of semaphorin for modulation of cellular efflux

Publications (1)

Publication Number Publication Date
CA2384104A1 true CA2384104A1 (en) 2001-03-15

Family

ID=27387351

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002384104A Abandoned CA2384104A1 (en) 1999-09-08 2000-09-07 Use of semaphorin for modulation of cellular efflux

Country Status (4)

Country Link
EP (1) EP1210368A2 (de)
AU (1) AU770157B2 (de)
CA (1) CA2384104A1 (de)
WO (1) WO2001018044A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002010217A2 (en) 2000-08-02 2002-02-07 The Johns Hopkins University Endothelial cell expression patterns
EP1429801A1 (de) * 2001-09-26 2004-06-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neuropilin als neuer therapeutischen zielpunkt zur modulation von immunantworten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639856A (en) * 1993-09-13 1997-06-17 The Regents Of The University Of California Semaphorin gene family
IT1270831B (it) * 1993-09-17 1997-05-13 Romano Deghenghi Composizioni farmaceutiche orali effervescenti contenenti estrone
WO1999021997A1 (en) * 1997-10-28 1999-05-06 Immunex Corporation Viral encoded semaphorin protein receptor dna and polypeptides
WO1999045114A2 (en) * 1998-03-03 1999-09-10 Zymogenetics, Inc. Human semaphorin zsmf-7

Also Published As

Publication number Publication date
AU770157B2 (en) 2004-02-12
EP1210368A2 (de) 2002-06-05
WO2001018044A3 (en) 2001-10-25
WO2001018044A2 (en) 2001-03-15
AU7355600A (en) 2001-04-10

Similar Documents

Publication Publication Date Title
US9447166B2 (en) Compositions and methods for the intracellular disruption of VEGF and VEGFR-2 by intraceptors
AU745235B2 (en) Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
EP1591530B1 (de) Tumornekrosefaktor-verwandter Ligand
AU9315298A (en) Kay - a novel immune system protein
PT975754E (pt) Proteínas e receptores para as proteínas de ligação de osteoprotegerina
JP2002538182A (ja) 新脈管形成を阻害するための方法および試薬
CA2429769C (en) Methods of treatment involving human mda-7
US6448078B1 (en) Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle
US8648045B2 (en) VDAC1 compositions and methods of use thereof for regulating apoptosis
Fischer et al. Cutting-edge apoptosis-based therapeutics: a panacea for cancer?
US6191269B1 (en) Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
AU770157B2 (en) Use of semaphorin for modulation of cellular efflux
US7176179B1 (en) Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide
Langel Clinical Trials and Commercialization Using CPPs
WO2001052883A1 (en) Inhibitors of protease-activated receptor-2 (par-2) as novel asthma therapeutics
WO2001017559A1 (en) Semaphorin modulation of immune cell migration
JP2006524712A (ja) カテプシンの阻害のための方法および組成物
WO2023049921A1 (en) Pd-l1 inhibitory peptide for cancer immunotherapy
WO2022056493A1 (en) Biomarker driven methods for treating major depressive disorder
CZ2000867A3 (cs) Sekvence DNA kódující ligand Kay, způsob přípravy ligandu Kay a farmaceutický přípravek obsahující tento ligand

Legal Events

Date Code Title Description
FZDE Dead